madecassic acid has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Fang, Y; Lv, C; Qiao, S; Tao, Y; Xia, Y; Yun, X | 1 |
1 other study(ies) available for madecassic acid and Colitis Gravis
| Article | Year |
|---|---|
Inhibition of the activation of γδT17 cells through PPARγ-PTEN/Akt/GSK3β/NFAT pathway contributes to the anti-colitis effect of madecassic acid.
Topics: Animals; Colitis, Ulcerative; Female; Humans; Interleukin-17; Mice; PPAR gamma; Triterpenes | 2020 |